Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crohn Disease in Remission”

132 trials

Showing 20 of 132 results

Post-approval studies (Phase 4)Study completedNCT02453776
What this trial is testing

Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab

Who this might be right for
Inflammatory Bowel Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 80
Testing effectiveness (Phase 2)Study completedNCT00329550
What this trial is testing

Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease

Who this might be right for
Crohn's Disease
UCB Japan Co. Ltd. 40
Not applicableStudy completedNCT06589895
What this trial is testing

Correlation Between RISANKIZUMAB's Trough Levels, Clinical and Biological Remission in Moderate to Severe Crohn's Disease: a Retrospective Multicentric Study

Who this might be right for
Inflammatory Bowel Diseases
Centre Hospitalier Universitaire de Nīmes 40
Testing effectiveness (Phase 2)Study completedNCT00055523
What this trial is testing

The Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Abbott 300
Post-approval studies (Phase 4)Ended earlyNCT02768532
What this trial is testing

Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease

Who this might be right for
Crohn Disease
Centre Hospitalier Universitaire de Saint Etienne 47
Not applicableStudy completedNCT05214430
What this trial is testing

Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery

Who this might be right for
Crohn Disease in Remission
Jinling Hospital, China 84
Large-scale testing (Phase 3)Study completedNCT00783692
What this trial is testing

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Millennium Pharmaceuticals, Inc. 1,116
Large-scale testing (Phase 3)Study completedNCT00152425
What this trial is testing

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Who this might be right for
Crohn's Disease
UCB Pharma 392
Not applicableEnded earlyNCT02930564
What this trial is testing

The Challenge Study: A Dietary Personalization Protocol for Patients With Crohn's Disease and Deep Remission

Who this might be right for
Crohn's Disease
Wolfson Medical Center 10
Post-approval studies (Phase 4)Study completedNCT01596894
What this trial is testing

Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease

Who this might be right for
Crohn's Disease
Prof. Arie Levine 73
Early research (Phase 1)Study completedNCT00868660
What this trial is testing

Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose

Who this might be right for
Inflammatory Bowel Disease
Zealand Pharma 66
Large-scale testing (Phase 3)Study completedNCT00552344
What this trial is testing

Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease

Who this might be right for
Crohn Disease
UCB BIOSCIENCES GmbH 403
Large-scale testing (Phase 3)Study completedNCT00944736
What this trial is testing

Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease

Who this might be right for
Crohn's Disease
Children's Mercy Hospital Kansas City 12
Large-scale testing (Phase 3)Ended earlyNCT01316939
What this trial is testing

GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 229
Not applicableUnknownNCT04912999
What this trial is testing

Inflammatory Bowel Diseases Remission Registry

Who this might be right for
Crohn DiseaseUlcerative ColitisPouchitis
Tel-Aviv Sourasky Medical Center 1,000
Large-scale testing (Phase 3)Looking for participantsNCT05660746
What this trial is testing

Precise Infliximab Exposure and Pharmacodynamic Control

Who this might be right for
Crohn Disease
Children's Hospital Medical Center, Cincinnati 180
Post-approval studies (Phase 4)Ended earlyNCT02392286
What this trial is testing

Corticosteroid Dosage for Crohn's Disease Flare

Who this might be right for
Crohn's DiseaseInflammatory Bowel Disease
Yale University 15
Large-scale testing (Phase 3)UnknownNCT04921033
What this trial is testing

Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease

Who this might be right for
Crohn DiseaseNutrient; ExcessRemission/Regression
Duzce University 256
Testing effectiveness (Phase 2)Ended earlyNCT03472690
What this trial is testing

QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Qu Biologics Inc. 20
Large-scale testing (Phase 3)Study completedNCT01224171
What this trial is testing

Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Millennium Pharmaceuticals, Inc. 416
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation